<p>Transcatheter aortic valve implantation (TAVI) is the preferred treatment for elderly patients with symptomatic severe aortic stenosis (SAS). Left atrial (LA) dysfunction is an established prognostic marker in various clinical settings. This study aimed to evaluate the correlation between LA function, assessed by strain parameters, and the incidence of permanent pacemaker (PPM) implantation or major adverse cardiovascular events (MACE) in patients with SAS undergoing TAVI. A total of 157 patients with SAS treated with TAVI between January 2019 and April 2021 were screened. Patients with pre-existing cardiac implanted devices or permanent atrial fibrillation were excluded. The mean follow-up was 24 ± 13 months. LA function was assessed using transthoracic echocardiography (TTE) by measuring three strain parameters: LA reservoir strain (LASr), LA conduit strain (LASct), and LA contractile strain (LAScd). The study endpoints were the association between these strain parameters and the occurrence of PPM implantation or MACE during follow-up. Ninety-nine patients were included in the analysis. During follow-up, 43 patients experienced MACE. Mean values for LASr, LASct, and LAScd were 29.5 ± 12.7%, -18.7 ± 11.0%, and − 18.5 ± 7.3%, respectively. Patients requiring PPM implantation showed significantly reduced LA strain values compared to those who did not (LASr: 13.1% vs. 33.2%; LASct: -10.1% vs. -21.0%; LAScd: -6.7% vs. -21.6%, <i>p</i> &lt; 0.001). Similarly, patients who developed MACE had reduced strain values compared to those without events (LASr: 21.9% vs. 35.4%; LASct: -14.3% vs. -21.8%; LAScd: -9.9% vs. -25.5%, <i>p</i> &lt; 0.001). Pre-TAVI LA dysfunction, assessed through LA strain, is closely associated with increased risk of PPM implantation and MACE.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Impaired left atrial strain as a predictor of bradyarrhythmias and clinical outcomes following TAVI

  • Giacomo Maria Viani,
  • Sven Lifka,
  • Vincenzo Viccaro,
  • Luca Bergamaschi,
  • Antonio Landi,
  • Andrea Milzi,
  • Elena Caporali,
  • Laura Anna Leo,
  • Giulio Conte,
  • Daniel Suerder,
  • Alessandro Caretta,
  • Maria Luce Caputo,
  • Tardu Oezkartal,
  • Carmine Pizzi,
  • Damiano Fedele,
  • Francesco Angeli,
  • Matteo Armillotta,
  • Amabile Valotta,
  • Giovanni Pedrazzini,
  • Marco Valgimigli,
  • Anna Giulia Pavon

摘要

Transcatheter aortic valve implantation (TAVI) is the preferred treatment for elderly patients with symptomatic severe aortic stenosis (SAS). Left atrial (LA) dysfunction is an established prognostic marker in various clinical settings. This study aimed to evaluate the correlation between LA function, assessed by strain parameters, and the incidence of permanent pacemaker (PPM) implantation or major adverse cardiovascular events (MACE) in patients with SAS undergoing TAVI. A total of 157 patients with SAS treated with TAVI between January 2019 and April 2021 were screened. Patients with pre-existing cardiac implanted devices or permanent atrial fibrillation were excluded. The mean follow-up was 24 ± 13 months. LA function was assessed using transthoracic echocardiography (TTE) by measuring three strain parameters: LA reservoir strain (LASr), LA conduit strain (LASct), and LA contractile strain (LAScd). The study endpoints were the association between these strain parameters and the occurrence of PPM implantation or MACE during follow-up. Ninety-nine patients were included in the analysis. During follow-up, 43 patients experienced MACE. Mean values for LASr, LASct, and LAScd were 29.5 ± 12.7%, -18.7 ± 11.0%, and − 18.5 ± 7.3%, respectively. Patients requiring PPM implantation showed significantly reduced LA strain values compared to those who did not (LASr: 13.1% vs. 33.2%; LASct: -10.1% vs. -21.0%; LAScd: -6.7% vs. -21.6%, p < 0.001). Similarly, patients who developed MACE had reduced strain values compared to those without events (LASr: 21.9% vs. 35.4%; LASct: -14.3% vs. -21.8%; LAScd: -9.9% vs. -25.5%, p < 0.001). Pre-TAVI LA dysfunction, assessed through LA strain, is closely associated with increased risk of PPM implantation and MACE.